Suppr超能文献

Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.

作者信息

Strand Siri H, Rivero-Gutiérrez Belén, Houlahan Kathleen E, Seoane Jose A, King Lorraine M, Risom Tyler, Simpson Lunden A, Vennam Sujay, Khan Aziz, Cisneros Luis, Hardman Timothy, Harmon Bryan, Couch Fergus, Gallagher Kristalyn, Kilgore Mark, We Shi, DeMichele Angela, King Tari, McAuliffe Priscilla F, Nangia Julie, Lee Joanna, Tseng Jennifer, Storniolo Anna Maria, Thompson Alastair M, Gupta Gaorav P, Burns Robyn, Veis Deborah J, DeSchryver Katherine, Zhu Chunfang, Matusiak Magdalena, Wang Jason, Zhu Shirley X, Tappenden Jen, Ding Daisy Yi, Zhang Dadong, Luo Jingqin, Jiang Shu, Varma Sushama, Anderson Lauren, Straub Cody, Srivastava Sucheta, Curtis Christina, Tibshirani Rob, Angelo Robert Michael, Hall Allison, Owzar Kouros, Polyak Kornelia, Maley Carlo, Marks Jeffrey R, Colditz Graham A, Hwang E Shelley, West Robert B

出版信息

Cancer Cell. 2023 Jul 10;41(7):1381. doi: 10.1016/j.ccell.2023.06.002.

DOI:10.1016/j.ccell.2023.06.002
PMID:37433282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10416265/
Abstract
摘要

相似文献

1
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.乳腺导管原位癌临床结局的分子分类及生物标志物：TBCRC 038和RAHBT队列分析
Cancer Cell. 2023 Jul 10;41(7):1381. doi: 10.1016/j.ccell.2023.06.002.
2
Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.男性乳腺癌前驱病变：欧洲癌症研究与治疗组织10085/TBCRC/BIG/NABCG国际男性乳腺癌项目分析
Mod Pathol. 2017 Apr;30(4):509-518. doi: 10.1038/modpathol.2016.229. Epub 2017 Jan 13.
3
Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).在粗针活检发现小叶肿瘤的患者中，相邻同步浸润性癌和/或导管原位癌的发生率：一项前瞻性多机构注册研究（TBCRC 020）的结果
Ann Surg Oncol. 2016 Mar;23(3):722-8. doi: 10.1245/s10434-015-4922-4. Epub 2015 Nov 5.
4
Breast cancers originating from the terminal ductal lobular units: In situ and invasive acinar adenocarcinoma of the breast, AAB.来源于终末导管小叶单位的乳腺癌：乳腺原位和浸润性腺样囊性癌，AAB。
Eur J Radiol. 2022 Jul;152:110323. doi: 10.1016/j.ejrad.2022.110323. Epub 2022 May 10.
5
Factors associated with residual disease after initial breast-conserving surgery for ductal carcinoma in situ.与导管原位癌初始保乳手术后残留病变相关的因素。
Hum Pathol. 2012 Jul;43(7):986-93. doi: 10.1016/j.humpath.2011.09.010. Epub 2012 Jan 4.
6
Potential biomarkers of ductal carcinoma in situ progression.导管原位癌进展的潜在生物标志物。
BMC Cancer. 2020 Feb 12;20(1):119. doi: 10.1186/s12885-020-6608-y.
7
Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.乳腺导管原位癌：形态学与分子相互作用的重要性
Hum Pathol. 2016 Mar;49:114-23. doi: 10.1016/j.humpath.2015.11.003. Epub 2015 Nov 17.
8
Microcysts and breast cancer: a study of biological markers in archival biopsy material.
Breast Cancer Res Treat. 2002 Oct;75(3):213-20. doi: 10.1023/a:1019969730552.
9
Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ.硫氧还蛋白相互作用蛋白是乳腺导管原位癌的独立危险分层因子。
Mod Pathol. 2018 Dec;31(12):1807-1815. doi: 10.1038/s41379-018-0086-7. Epub 2018 Jun 28.
10
Ductal carcinoma in situ of breast: detection and treatment pattern in Hong Kong.乳腺导管原位癌：香港的检测与治疗模式
Hong Kong Med J. 2017 Feb;23(1):19-27. doi: 10.12809/hkmj154754. Epub 2016 Oct 24.

引用本文的文献

1
Single-Cell Expression Analysis of Ductal Carcinoma In Situ Identifies Complex Genotypic-Phenotypic Relationships Altering Epithelial Composition.导管原位癌的单细胞表达分析揭示改变上皮成分的复杂基因型-表型关系。
Cancer Res. 2025 Jun 16;85(12):2302-2319. doi: 10.1158/0008-5472.CAN-24-3023.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验